biotech
Vion Pharmaceuticals Licenses Heterocyclic Hydrazones
Filed in archive Corporate and Industrial News , Patents and Intellectual Property Rights by ruth on September 27, 2005
BlogPicture

Don't you wish there were more banks and institutes like the Austria Wirtschaftsservice Gesellschaft m.b.H. (aws) who facilitate the marketing of promising innovations and technologies? In this case, this bank mainly mainly focuses on bring outputs from Austrian universities to industry. Just yesterday, it was able to mediate the exclusive licensing agreement between the Institute of Pharmacy and the Institute of Medical Chemistry and Biochemistry at the University of Innsbruck and Vion Pharmaceuticals over a group of heterocyclic hydrazone compounds covered by patents or patent applications in North America and Europe.
"The hydrazones have unique chemical structures and biologic activity, and have shown potent cytotoxic activity in the National Cancer Institute's tumor cell panels and in vivo anticancer testing. We are pleased to have the opportunity to develop these potential clinical candidates under an exclusive license agreement."


Under the agreement, Vion will make an initial payment of $37,500 to the inventors and aws, and additional milestone payments based on the progress of clinical development and royalties based on product revenues.

Read more here.

Permalink: Vion Pharmaceuticals Licenses Heterocyclic Hydrazones
Tags: cancer  patent  biotech  vion  heterocyclic  vion+pharmaceuticals  licenses+heterocyclic  pharmaceuticals+l 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/9751
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Vion Pharmaceuticals Licenses Heterocyclic Hydrazones:

  • Currently 6.67/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.67 out of 3 vote(s) cast.
 
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!